Vitamin D and diabetes.

Laboratory of Experimental Medicine and Endocrinology (LEGENDO), Catholic University of Leuven, Herestraat 49, 3000, Leuven, Belgium.
Diabetologia (Impact Factor: 6.88). 08/2005; 48(7):1247-57. DOI: 10.1007/s00125-005-1802-7
Source: PubMed

ABSTRACT Vitamin D deficiency predisposes individuals to type 1 and type 2 diabetes, and receptors for its activated form-1alpha,25-dihydroxyvitamin D3-have been identified in both beta cells and immune cells. Vitamin D deficiency has been shown to impair insulin synthesis and secretion in humans and in animal models of diabetes, suggesting a role in the development of type 2 diabetes. Furthermore, epidemiological studies suggest a link between vitamin D deficiency in early life and the later onset of type 1 diabetes. In some populations, type 1 diabetes is associated with certain polymorphisms within the vitamin D receptor gene. In studies in nonobese diabetic mice, pharmacological doses of 1alpha,25-dihydroxyvitamin D3, or its structural analogues, have been shown to delay the onset of diabetes, mainly through immune modulation. Vitamin D deficiency may, therefore, be involved in the pathogenesis of both forms of diabetes, and a better understanding of the mechanisms involved could lead to the development of preventive strategies.

Download full-text


Available from: Conny Gysemans, Sep 16, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Of the vitamins that help maintain health, vitamin D holds a very important place. Its deficiency is a major global health p roblem and affects both genders at all stages of life. Lack of exposure to the sunlight is among the foremost of the causes of vitamin D deficiency. However, contemporary literature reveals an interesting paradox in the Middle East where abundant sunshine and vitamin D deficiency coexist. The conundrum acquires further co mplexity when we consider the so far unresolved debate on the right reference range, dietary reco mmendations, the difference of assessment methods and ranges in the various different laboratories world wide, continuously emerging new and more accurate methods of serum vitamin D assessment though with limited availability and the debate regarding the most accurate method currently available for measuring its seru m levels. Furthermore, the literature on the M iddle East reveals that wo men are affected more than men. Generally, vitamin D level estimations have been found to be quite low across all age groups in this region. Old age, female gender, mu lti-parity, winter season, clothing style, lo w socioeconomic status and urban living have consistently been associated with low levels of vitamin D in the literature. A lmost similar deficiency levels are found in regions with different socio-cultural norms but comparable weather. Further studies are needed to establish the correct reference range, dietary recommendations, the risk-benefit rat io of exposure to the sunshine and the most accurate laboratory method of its serum level assessment for the population in this region.
    Journal of health science 01/2012; 2(6):49-56. DOI:10.5923/ · 0.80 Impact Factor
  • Source
    Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments, 11/2011; , ISBN: 978-953-307-756-7
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In-vitro and observational studies have established a link between vitamin D deficiency and different type 2 diabetes outcomes (insulin resistance, insulin secretion, glucose intolerance). Although the number of randomized controlled trials vs placebo is small, vitamin D (VTD) has been shown to prevent increases in glucose concentration and insulin resistance, enhance insulin sensitivity and reduce systolic blood pressure in type 2 diabetic patients. In this review, we have focused on the potential mechanisms that might explain the association between VTD and type 2 diabetes mellitus (T2DM). We have also evaluated the different epidemiological and observational studies on the topic, as well as the various interventional studies. Although the in vitro studies appear to be promising in explaining the link between VTD metabolism and T2DM, the results of in vivo studies are conflicting. This could be related to differences in their methodological approaches. Although more studies are needed to confirm the role of VTD in the treatment of T2DM, there is nevertheless enough evidence at this time to suggest a need to maintain 25-OH vitamin D levels in T2DM patients around 30 ng/mL over the course of a year.
    Diabetes & Metabolism 02/2011; 37(4):265-72. DOI:10.1016/j.diabet.2011.01.001 · 2.85 Impact Factor